Clinical trial
Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations
NCT00334711 · Royal Devon and Exeter NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00334711 |
|---|---|
| Title | Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations |
| Official title | A Prospective Study of Sulfonylureas in Patients With Diabetes Due to Kir6.2 Mutations |
| Lead sponsor | Royal Devon and Exeter NHS Foundation Trust, Other |
| Collaborators | Wellcome Trust Hôpital Necker-Enfants Malades Haukeland University Hospital |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Sulfonylurea |
| Enrollment | 50 |
| Start date | Jan 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Jun 8, 2006 |
| Last update posted | Nov 29, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: